Ultimele actualizari :
01/10/2024
Citostatic   Cetuximab  
Injectabil
Stabilitatea in solutie Stabilitatea in amestec Factorii care influenteaza stabilitatea Compatibilitate Microunde Bibliografie pdf

Denumirea comerciala   Denumirea comerciala     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Erbitux Africa de Sud, Argentina, Australia, Austria, Belgia, Canada, Chilli, Columbia, Danemarca, Ecuador, Elvetia, Finlanda, Franta, Germania, Grecia, India, Iran, Irlanda, Islanda, Italia, Japonia, Luxemburg, Malaezia, Mexic, Norvegia, noua Zeelandă, Olanda, Peru, Polonia, Romania, Spania, SUA, Suedia, Turcia, Ungaria, Venezuela
Bibliografie   Injectabil   Bibliografie : Cetuximab  
tip publicare
2220 Laborator Cétuximab (Erbitux®) - Dossier scientifique
Merck Serono 2015
2296 Laborator Témocilline (Negaban®) - Résumé des caractéristiques du produit
Eumedica 2017
4755 ziar Vieillard V, Le Guyader G, Jallades A, Astier A.
Extended physicochemical stability of cetuximab in opened vials and infusion bags when stored at 4°C and 25°C.
J Oncol Pharm Practice 2023
4819 ziar Carpanese D, Rossi V, Di Paolo V, Quintieri L, Penna Zuccolotto G, Sebellin J, Saran C, Pipitone F, Miolo G, de Diana E et al.
Prolonging the stability of cetuximab (Erbitux®) and panitumumab (Vectibix®): An orthogonal assessment of physicochemical, biological and microbiological properties of original opened glass vials and diluted saline preparations.
Int J Pharm 2024 ; 649: 123643.

  Mentions Légales